STRIDES PHARMA SCI LTD (STAR) financials

STRIDES PHARMA SCI LTD (STAR) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products.[1]The company's pharmaceutical products are sold in over 100 countries.[2]The company has always followed an inorganic growth strategy over the years that resulted in foray into new markets, addition of new business segments, therapy segments and manufacturing infrastructure.[3]

Market Cap: ₹9,634Cr.
Current Price: ₹1,045
Stock P/E: 53.5
ROE: 2.27%
ROCE: 4.88%
Book Value: ₹356
Dividend Yield: 0.48%
52W High / Low: ₹1,261/769

In Jun 2026, STRIDES PHARMA SCI LTD (STAR) reported sales ₹583 Cr and net profit ₹73 Cr.

Annual TTM: sales ₹2,264 Cr, net profit ₹243 Cr.

Shareholding: Promoters 29.00% (Sep 2026), FIIs 27.98% (Sep 2026), DIIs 15.51% (Sep 2026), Government 0.01% (Sep 2026), Public 27.52% (Sep 2026).

STAR quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	520	551	556	499	522	554	606	583
Expenses	464	477	488	431	460	472	531	522
Operating Profit	55	74	68	67	62	81	74	61
OPM %	11%	13%	12%	13%	12%	15%	12%	10%
Other Income	24	2	12	2	14	103	4	78
Interest	42	34	29	30	29	27	27	29
Depreciation	21	21	22	22	22	22	25	26
Profit before tax	16	21	28	16	25	135	27	85
Tax %	-5%	30%	43%	19%	-26%	10%	38%	14%
Net Profit	17	15	16	13	32	122	16	73
EPS in Rs	1.88	1.62	1.75	1.45	3.48	13.23	1.77	7.91
Raw PDF	—	—	—	—	—	—	—	—

STAR profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	1,692	1,858	1,979	1,854	1,866	2,139	2,180	2,264
Expenses	1,487	1,698	1,902	1,755	1,715	1,877	1,893	1,985
Operating Profit	205	159	77	100	151	263	287	279
OPM %	12%	9%	3.9%	5%	8%	12%	13%	12%
Other Income	93	117	123	68	122	2,873	121	199
Interest	67	65	74	139	139	146	114	112
Depreciation	94	99	104	94	87	85	91	95
Profit before tax	136	112	22	-65	46	2,905	203	271
Tax %	12%	30%	-738%	-107%	3%	1%	10%	—
Net Profit	120	78	180	5	45	2,886	184	243
EPS in Rs	13.42	8.72	20.07	0.52	4.85	313.04	19.92	26.39
Dividend Payout %	104%	29%	0%	289%	52%	1%	25%	—

STAR balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	90	90	90	90	90	92	92	92
Reserves	3,167	3,069	3,158	3,317	3,365	3,436	3,101	3,191
Borrowings	811	902	917	1,284	1,414	1,688	1,202	1,184
Other Liabilities	595	616	1,056	743	750	687	636	928
Total Liabilities	4,663	4,677	5,221	5,434	5,620	5,902	5,031	5,396
Fixed Assets	574	651	644	617	597	747	767	785
CWIP	122	112	111	56	55	107	106	181
Investments	2,149	2,171	2,395	2,400	2,492	2,364	1,848	1,868
Other Assets	1,818	1,743	2,072	2,361	2,476	2,684	2,311	2,561
Total Assets	4,663	4,677	5,221	5,434	5,620	5,902	5,031	5,396

STAR cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	40	138	283	-283	242	-14	421	278
Cash from Investing Activity	-166	63	-276	19	-183	-69	-138	-69
Cash from Financing Activity	123	-204	-49	251	11	93	-370	-199
Net Cash Flow	-3	-3	-42	-13	70	11	-86	10
Free Cash Flow	-42	68	196	-350	161	-89	264	116
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	57%	83%	73%	-397%	142%	-45%	114%	97%

STAR shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	26.82%	28.30%	28.30%	27.86%	27.86%	27.91%	27.91%	29.00%
FIIs	28.48%	28.32%	28.02%	28.51%	29.52%	28.68%	28.40%	27.98%
DIIs	16.92%	13.72%	13.30%	12.98%	13.02%	14.44%	15.42%	15.51%
Government	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
Public	27.78%	29.65%	30.38%	30.62%	29.59%	28.96%	28.28%	27.52%
No. of Shareholders	1,14,236	95,125	92,889	91,206	85,589	86,616	94,850	93,336

STAR key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	138	141	161	239	257	306	248	255
Inventory Days	197	189	254	170	168	188	145	191
Days Payable	212	200	271	213	220	205	163	225
Cash Conversion Cycle	123	130	144	196	205	289	230	220
Working Capital Days	-14	-37	16	22	48	41	83	83
ROCE %	4%	5%	4%	2%	2%	2%	5%	5%

STARUpdated 18 Oct 2026, 6:06

Strides Pharma Sci Ltd

STARUpdated 18 Oct 2026, 6:06

Market Cap

₹9,634Cr.

Current Price

₹1,045

High / Low

₹1,261/769

Stock P/E

53.5

ROE2.27%

ROCE4.88%

Book Value₹356

Face Value₹10.0

Dividend Yield0.48%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	475	37	420	12	21	9	12	8	0.89
Sep 2023	553	42	514	19	23	-7	-1	-7	-0.75
Dec 2023	380	36	378	60	22	3	112	0	-0.04
Mar 2024	603	39	492	-1	22	49	-6	52	5.65
Jun 2024	586	48	520	8	22	4	33	2	0.26
Sep 2024	520	42	464	24	21	16	-5	17	1.88
Dec 2024	551	34	477	2	21	21	30	15	1.62
Mar 2025	556	29	488	12	22	28	43	16	1.75
Jun 2025	499	30	431	2	22	16	19	13	1.45
Sep 2025	522	29	460	14	22	25	-26	32	3.48
Dec 2025	554	27	472	103	22	135	10	122	13.23
Mar 2026	606	27	531	4	25	27	38	16	1.77
Jun 2026	583	29	522	78	26	85	14	73	7.91

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	929	34	795	619	49	669	20	532	89.32
Mar 2016	2162	103	1894	82	103	145	10	130	14.58
Mar 2017	1382	72	1255	154	70	139	22	109	12.14
Mar 2018	1470	82	1271	860	78	899	1	892	99.62
Mar 2019	1537	54	1402	111	83	109	-1	110	12.33
Mar 2020	1692	67	1487	93	94	136	12	120	13.42
Mar 2021	1858	65	1698	117	99	112	30	78	8.72
Mar 2022	1979	74	1902	123	104	22	-738	180	20.07
Mar 2023	1854	139	1755	68	94	-65	-107	5	0.52
Mar 2024	1866	139	1715	122	87	46	3	45	4.85
Mar 2025	2139	146	1877	2873	85	2905	1	2886	313.04
Mar 2026	2180	114	1893	121	91	203	10	184	19.92
TTM	2264	112	1985	199	95	271	—	243	26.39

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	29%
FIIs	27.98%
DIIs	15.51%
Government	0.01%
Public	27.52%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Government	Public
Dec 2023	27.39%	19.45%	19.02%	0.39%	33.75%
Mar 2024	25.88%	24.57%	17.66%	0.39%	31.52%
Jun 2024	25.86%	26.71%	18.17%	0.39%	28.87%
Sep 2024	25.84%	30.08%	18.24%	0.01%	25.83%
Dec 2024	26.82%	28.48%	16.92%	0.01%	27.78%
Mar 2025	28.3%	28.32%	13.72%	0.01%	29.65%
Jun 2025	28.3%	28.02%	13.3%	0.01%	30.38%
Sep 2025	27.86%	28.51%	12.98%	0.01%	30.62%
Dec 2025	27.86%	29.52%	13.02%	0.01%	29.59%
Mar 2026	27.91%	28.68%	14.44%	0.01%	28.96%
Jun 2026	27.91%	28.4%	15.42%	0.01%	28.28%
Sep 2026	29%	27.98%	15.51%	0.01%	27.52%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	60	1415	405	273	2152	394	39	968	750	2152
Mar 2016	89	3068	1545	602	5304	984	180	2447	1693	5304
Mar 2017	89	3143	1608	641	5481	1194	158	2520	1609	5481
Mar 2018	90	3073	606	517	4285	564	144	1777	1801	4285
Mar 2019	90	3167	811	595	4663	574	122	2149	1818	4663
Mar 2020	90	3069	902	616	4677	651	112	2171	1743	4677
Mar 2021	90	3158	917	1056	5221	644	111	2395	2072	5221
Mar 2022	90	3317	1284	743	5434	617	56	2400	2361	5434
Mar 2023	90	3365	1414	750	5620	597	55	2492	2476	5620
Mar 2024	92	3436	1688	687	5902	747	107	2364	2684	5902
Mar 2025	92	3101	1202	636	5031	767	106	1848	2311	5031
Mar 2026	92	3191	1184	928	5396	785	181	1868	2561	5396

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	207	305	-802	-290
Mar 2016	83	-1062	1571	592
Mar 2017	412	-883	-67	-538
Mar 2018	66	433	-707	-208
Mar 2019	40	-166	123	-3
Mar 2020	138	63	-204	-3
Mar 2021	283	-276	-49	-42
Mar 2022	-283	19	251	-13
Mar 2023	242	-183	11	70
Mar 2024	-14	-69	93	11
Mar 2025	421	-138	-370	-86
Mar 2026	278	-69	-199	10

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	101	117	143	112	138	141	161	239	257	306	248	255
Inventory Days	110	113	204	126	197	189	254	170	168	188	145	191
Days Payable	133	148	234	183	212	200	271	213	220	205	163	225
Cash Conversion Cycle	77	82	112	55	123	130	144	196	205	289	230	220
Working Capital Days	33	28	-61	1	-14	-37	16	22	48	41	83	83
ROCE %	9%	6%	5%	24%	4%	5%	4%	2%	2%	2%	5%	5%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of STRIDES PHARMA SCI LTD (STAR)?

The reported market capitalisation for STRIDES PHARMA SCI LTD (STAR) is ₹9,634Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of STAR?

The current price shown for STRIDES PHARMA SCI LTD (STAR) on Fincrux is ₹1,045 with a 52-week high/low of ₹1,261/769.

What is the P/E ratio of STRIDES PHARMA SCI LTD (STAR)?

The stock P/E for STRIDES PHARMA SCI LTD (STAR) is 53.5 on Fincrux, with ROE at 2.27% and ROCE at 4.88%.

What were STAR latest quarterly results?

For Jun 2026, STRIDES PHARMA SCI LTD (STAR) reported sales ₹583 Cr and net profit ₹73 Cr (figures in ₹ crore unless noted).

What are STAR annual sales and net profit?

For TTM, STRIDES PHARMA SCI LTD (STAR) shows sales of ₹2,264 Cr and net profit of ₹243 Cr on the Fincrux profit & loss statement.

Who owns STRIDES PHARMA SCI LTD (STAR)?

Latest shareholding for STRIDES PHARMA SCI LTD (STAR) on Fincrux: Promoters 29.00% (Sep 2026), FIIs 27.98% (Sep 2026), DIIs 15.51% (Sep 2026), Government 0.01% (Sep 2026), Public 27.52% (Sep 2026).

Where can I find STRIDES PHARMA SCI LTD (STAR) financials?

STRIDES PHARMA SCI LTD (STAR) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show STAR balance sheet and cash flow?

Yes. The STRIDES PHARMA SCI LTD (STAR) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 6:06